The Spectrum of Fluctuations in Living Matter

This project aims to develop a theoretical framework for predicting active fluctuations in living matter by analyzing subcellular and tissue-scale dynamics, enhancing our understanding of biological processes.

Subsidie
€ 1.499.575
2024

Projectdetails

Introduction

Living matter is active: It is driven far from thermodynamic equilibrium by irreversible microscopic processes, such as the action of molecular motors and cell division. This microscopic activity generates nonequilibrium fluctuations, which overwhelm thermal noise and impact biological processes across scales, from intracellular transport to tumour formation.

Knowledge Gap

However, unlike in the case of thermal fluctuations, we have no theoretical framework like the fluctuation-dissipation theorem to predict the statistical properties of active fluctuations. Here, I propose to address this knowledge gap by means of theoretical research combined with experimental collaborations organized in two aims.

Aim 1: Subcellular Scale

In the first aim, at the subcellular scale, we will predict the spectrum of active noise based on the nonequilibrium binding kinetics of cytoskeletal proteins.

To this end, we will:

  1. Coarse-grain a cytoskeletal network model in which detailed balance is explicitly broken at the molecular scale.
  2. Use the predictions to analyze experimental data and infer features of molecular activity in living cells and in the mitotic spindle.

Aim 2: Tissue Scale

In the second aim, at the tissue scale, we will predict the statistical properties of active pressure fluctuations due to stochastic cell proliferation, which is itself regulated by pressure.

We will establish how this mechanical feedback affects the spectrum of the pressure field in a growing tissue. To this end, we will:

  1. Generalize tools from the renormalization group that were originally developed to study nonequilibrium critical phenomena through the Kardar-Parisi-Zhang equation.
  2. Collaborate with experimentalists to test our predictions by measuring the spectrum of pressure fluctuations in living tissues for the first time.

Conclusion

Overall, this research will lay the basis of a stochastic hydrodynamics of living materials and, at the same time, reveal how active fluctuations promote biological functions in cells and tissues.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 1.499.575
Totale projectbegroting€ 1.499.575

Tijdlijn

Startdatum1-1-2024
Einddatum31-12-2028
Subsidiejaar2024

Partners & Locaties

Projectpartners

  • MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EVpenvoerder

Land(en)

Germany

Vergelijkbare projecten binnen European Research Council

ERC Starting...

Nanoprobes for Nonequilibrium Driven Systems

This project aims to develop fluorescent nanosensors to quantify energy dissipation in nonequilibrium biological systems, enhancing understanding of molecular motors and thermodynamic constraints.

€ 1.500.000
ERC Starting...

Programmable Active Matter

This project aims to develop a controlled in-vitro system using biological components to study phase transitions in living matter, enhancing understanding of self-organization and potential industrial applications.

€ 1.903.750
ERC Advanced...

The Stressed Cell as a Physical Aging Problem

This project aims to develop a statistical physics framework to analyze cellular responses to acute stress, revealing network dynamics and informing synthetic biology and treatment strategies.

€ 2.497.500
ERC Consolid...

Hidden states and currents in biological systems

This project aims to revolutionize the understanding of hidden dynamics in various systems by developing new statistical methods for analyzing time series data, enhancing insights in biophysics and beyond.

€ 2.000.000
ERC Consolid...

NONLINEAR DYNAMICS OF FLUCTUATING TWO-DIMENSIONAL MATERIALS IN ACTION

NCANTO aims to harness nonlinear dynamics in 2D materials to create highly-sensitive nanomechanical devices for improved frequency stability and single-cell sensing in drug development.

€ 1.999.021